Tucson, Ariz. (February 1, 2023) – The PGA TOUR Champions, the Tucson Conquistadores, the First Tee Tucson, and Exact Sciences, the maker of Cologuard®, announced today that the Madison, Wisconsin-based company will now be the presenting sponsor of the Cologuard Classic. The announcement also extends Cologuard’s title sponsorship through the 2027 season. The 2023 Cologuard Classic by Exact Sciences will take place at the Omni Tucson National Resort from February 27th through March 5th and will have a $2.2 million purse, with $330,000 to the winner.Continue reading
Author Archive: AZBio
AZAdvances Talent Program Internship Opportunities
A component of the AZAdvances Talent Program, AZAdvances internships are designed to support Arizona students as they explore career paths in health and life sciences. Internships are created in partnership with AZBio member organizations and are supported though grants and donations to the Opportunity Through Entrepreneurship Foundation’s benefiting the AZAdvances initiative.Continue reading
A Natural Non-invasive Neuro-technology Improves Sleep and Wellbeing in Randomized, Controlled Clinical Trial
The Post-COVID world has an increased population suffering from sleep issues, and good sleep is the basis to good health. An insomnia intervention which is natural and non-invasive can be an important aspect to achieve improved health in a post-COVID world.Continue reading
Arizona’s Opportunity to Drive Health Innovation Forward Faster
In 2022, Arizona established the Arizona Health Innovation Trust Fund as a vehicle to drive the creation of health innovations that can improve quality of life for people of Arizona and increase opportunities for the high quality jobs Arizona Health Innovators create. The FY2023 appropriation was $100,000 to allow the initial set up of the fund. In 2023, two bills at the Arizona Legislature (HB2253 and SB1084) propose a $200 million dollar one-time investment into the Arizona Health Innovation Trust Fund.Continue reading
C-Path’s TRxA Announces its First Global Request for Proposals from Academic Investigators Working to Advance Drug Development Projects
Launched in 2022, the Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients. TRxA is now accepting applications for its 2023 funding cycle.Continue reading
AdvaMed Outlines Four Key Priorities in Letter to President on Sterilization
WASHINGTON, D.C. – In a letter to the White House, the Advanced Medical Technology Association (AdvaMed) outlined four key priorities in pending regulations for facilities sterilizing medical devices with ethylene oxide (EtO).Continue reading
AZBio Introduces Leadership Team for its 20th Anniversary Year
AZBio Elected its 2023 leadership team during its January Board of Directors meeting on the Medtronic Tempe campus. Following the meeting Medtronic hosted members of Arizona’s Life Science Community for a reception kicking off AZBio’s third decade.Continue reading
Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-molecule Proteomics Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)
Collaboration enables TGen to gain access to data generated on prototype versions of Nautilus’ next-generation proteome analysis platform to advance the study of a rare childhood cancer
Eurofins CellTx Cellular Therapy-Focused Laboratory Opens at UA Tech Park in Tucson, Arizona
Tucson, AZ (January 19, 2023) – Eurofins CellTx which provides comprehensive laboratory services to meet the unique testing and processing needs of the transplant community, has officially began operating in the new laboratory located at the University of Arizona (UA) Tech Park.Continue reading